Medical education provider Medscape has bowed to pressure and agreed to permanently remove a series of accredited medical education courses on smoking cessation funded by the tobacco industry giant Philip Morris International (PMI), The BMJ and The Examination have found.
Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL
Lisocabtagene maraleucel (liso-cel), a CAR T-cell therapy, is a cost effective second line treatment for relapsed and refractory (hard to treat) diffuse large B-cell lymphoma
December 29, 2023